Simplified MethylRAD Sequencing to Detect Changes in DNA Methylation at Enhancer Elements in Differentiating...

Area of Science:

• Epigenetics
• Genomics
• Developmental Biology

Background:

• Differential DNA methylation characterizes gene regulatory regions like enhancers, often with low or intermediate CpG content, making methylation quantification challenging.
• Genome-wide bisulfite sequencing is expensive and cumbersome for measuring fractional DNA methylation changes at specific sites, especially across the largely methylated mammalian genome.

Purpose of the Study:

• To develop and validate a novel technique, MethylRAD, for accurately assessing regional DNA methylation changes in embryonic stem cells (ESCs) during differentiation.
• To investigate the role of DNA methylation in the silencing of pluripotency genes (PpGs) and their enhancers (PpGes) during ESC differentiation, particularly concerning the enzyme LSD1.

Main Methods:

• Development of the MethylRAD technique, featuring an improved experimental design and bioinformatic analysis tool.
• Application of MethylRAD to examine regional DNA methylation dynamics in ESCs undergoing differentiation, including experiments with an LSD1 inhibitor.

Main Results:

• MethylRAD successfully detected regional DNA methylation changes in ESCs during differentiation.
• In the presence of an LSD1 inhibitor, a substantial portion of LSD1-bound PpGes failed to gain DNA methylation, an effect pronounced in low/intermediate CpG content regions.
• The study confirmed that MethylRAD is sensitive and accurate for detecting subtle DNA methylation alterations in regulatory regions.

Conclusions:

• MethylRAD is a sensitive, accurate, and cost-effective method for quantifying DNA methylation changes in regulatory regions, including those with low/intermediate CpG content.
• The findings highlight the utility of MethylRAD for studying epigenetic regulation during cellular differentiation and its potential for diagnostic applications.